Science & Enterprise subscription

Follow us on Twitter

  • An industry-academic consortium received a U.S. government contract to develop coded synthetic polymer chemicals li… https://t.co/AqWMpFYG5Q
    about 16 hours ago
  • New post on Science and Enterprise: Synthetic DNA Studied for Mass Data Storage https://t.co/XeKsILkGR0 #Science #Business
    about 16 hours ago
  • Engineers developed a more sustainable type of concrete adding a form of bacteria to grow and reproduce the materia… https://t.co/7naaOf9CYF
    about 20 hours ago
  • New post on Science and Enterprise: Living, Reproducing Concrete Created with Bacteria https://t.co/1RWPEfpvmz #Science #Business
    about 20 hours ago
  • Smart money? The US company receiving the most venture capital money through 2019 is e-cigarette maker Juul Labs, a… https://t.co/YHMyj4Aavo
    about 2 days ago

Please share Science & Enterprise

Synthetic DNA Studied for Mass Data Storage

DNA illustration

An industry-academic consortium received a U.S. government contract to develop coded synthetic polymer chemicals like DNA for reliably storing massive amounts of data. . . . → Read More: Synthetic DNA Studied for Mass Data Storage

Organoid in Chip Device Better Simulates Gut Functions

Tissue on intestine chip

A chip device simulating intestinal functions, bolstered by a gut tissue organoid, behaves more like a human intestine in lab tests than the gut organoid alone. . . . → Read More: Organoid in Chip Device Better Simulates Gut Functions

Venture Philanthropy Funds Rare Neuro Disease Trial

Neurons illustration

A gene therapy start-up is receiving an award resembling venture financing to advance its treatment for a rare inherited neuromuscular disorder to clinical trials. . . . → Read More: Venture Philanthropy Funds Rare Neuro Disease Trial

Trial Underway Testing Crispr-Based Antibiotic

E. coli

A clinical trial is recruiting participants to test an antibiotic made with engineered viruses, in people threatened with urinary tract infections from E. coli bacteria. . . . → Read More: Trial Underway Testing Crispr-Based Antibiotic

A.I. Discovery Companies to Find Rare Disease Drugs

Synthetic biology

A joint venture of two drug discovery and design companies aims to create new biotechnology businesses to find drugs for treating rare diseases. . . . → Read More: A.I. Discovery Companies to Find Rare Disease Drugs

Science & Enterprise Year in Review

Crispr explainer

Our most-viewed new story is from an academic/industry research team in Australia that tells how a synthetic cannabidiol, or CBD, compound is as effective as current antibiotics against a class of microbes. . . . → Read More: Science & Enterprise Year in Review

Commentary – New Models Needed for Antibiotic Resistance

MRSA bacteria

Many parts of a new model for fighting antibiotic resistance are in development, and the pieces still need to be assembled, but the outline of a precision-medicine rather than mass-produced drug model is beginning to emerge. . . . → Read More: Commentary – New Models Needed for Antibiotic Resistance

Tomato Genetics Altered for Urban Farms

Gene-altered tomatoes

Plant scientists used a genome-editing technique to produce varieties of tomatoes better suited for growing on urban farms and other small plots. . . . → Read More: Tomato Genetics Altered for Urban Farms

Supermarkets to Offer Genetic Mental Health Test

Acme Market

A chain of supermarket pharmacies in Pennsylvania will begin offering genetic tests to help customers manage their mental health medications. . . . → Read More: Supermarkets to Offer Genetic Mental Health Test

Viruses Altered to Boost Gene Therapy Delivery

Neurons

Researchers in Sweden developed a process to improve the targeting of benign viruses for delivering gene therapies to the brain. . . . → Read More: Viruses Altered to Boost Gene Therapy Delivery